»Ê¼Ò»ªÈË

Pharma and medtech stocks can offer investors safety if and when Big Tech falters. We highlight where to look

Fiscal pressures will see more government functions given over to private interests

The easy trade might be over, but investors can jump on the next leg by backing early adopters

We reveal the best active funds for your portfolio

The best defensive funds

Our selection of the best growth funds

The best funds in ‘alternative’ asset classes

The best funds for dividend hunters

We reveal the best active funds to grow and protect your portfolios

Bargain Shares 2026: A strategic review means management is shedding low-margin brands and finding lucrative bolt-on acquisitions

Bargain Shares 2026: The low share price ignores a strong balance sheet, good cash levels and a decent income

Bargain Shares 2026: It banked a huge profit from selling an Australian subsidiary and cash returns to investors are likely

Bargain Shares 2026: The business is holding cash, and any positive news from its savvy investments will see shares re-rate